As the Head of Regulatory Solutions at DLRC Regulatory Consultancy, Kevin Judges brings over three decades of extensive experience in global drug regulatory affairs and pharmaceutical development. His role is pivotal in guiding clients through the complex landscape of regulatory submissions, ensuring that new drug...
As the Head of Regulatory Solutions at DLRC Regulatory Consultancy, Kevin Judges brings over three decades of extensive experience in global drug regulatory affairs and pharmaceutical development. His role is pivotal in guiding clients through the complex landscape of regulatory submissions, ensuring that new drug and clinical trial applications are meticulously prepared and managed for success in both European and US markets. Kevin’s deep expertise spans various therapeutic areas, including oncology and infectious diseases, where he leverages his comprehensive knowledge of regulatory frameworks to develop innovative strategies tailored to each client’s unique needs.
At DLRC, a consultancy renowned for its commitment to excellence, Kevin leads a dedicated team of highly qualified regulatory affairs professionals across offices in the UK, Germany, and the United States. Together, they collaborate with a diverse clientele, ranging from top-tier pharmaceutical companies to small and medium-sized enterprises (SMEs), to navigate the intricacies of drug development from early product conception through to post-licensing. His leadership in cross-functional team environments ensures that regulatory strategies are not only compliant but also aligned with broader business objectives, facilitating efficient clinical development and trial execution.
Kevin’s proficiency in preparing Investigational New Drug (IND) applications and his strategic insights into the pharmaceutical industry empower clients to expedite their drug development processes while minimizing regulatory hurdles. His commitment to fostering strong partnerships and delivering results has established him as a trusted advisor in the field, making significant contributions to the advancement of healthcare solutions globally.